![Eske Rygaard-Hjalsted](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Eske Rygaard-Hjalsted
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Eske Rygaard-Hjalsted
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Eske Rygaard-Hjalsted
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
University of Copenhagen | College/University | Doctorate Degree Graduate Degree Doctorate Degree | |
K:2 Holding ApS | Chief Executive Officer | ||
NOVO NORDISK A/S | Pharmaceuticals: Major | Sales & Marketing | |
CooperSurgical, Inc.
![]() CooperSurgical, Inc. Medical SpecialtiesHealth Technology CooperSurgical, Inc. develops, manufactures, and markets medical instruments. It offers surgical, clinical and practice based, labor and delivery and critical care. The firm’s surgical products include C-section retractors, hysterectomy/laparoscopic instruments and laparoscopic port-site closures. The company was founded in 1990 and is headquartered in Trumbull, CT. | Medical Specialties | Corporate Officer/Principal | |
Origio A/S
![]() Origio A/S BiotechnologyHealth Technology ORIGIO A/S manufactures and markets assisted reproduction technologies and related human reproductive products. Its products include Andrology, sequential series, EmbryoGem, BlastGen, Pipettes, ICSI micropipets. The company was founded in 1987 and is headquartered in Maaloev, Denmark. | Biotechnology | Corporate Officer/Principal | |
HYDRACT A/S | Industrial Machinery | Director/Board Member | |
Technical University of Denmark | College/University | Graduate Degree | |
ExpreS2ion Biotechnologies ApS
![]() ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology ExpreS2ion Biotechnologies ApS operates as a biotechnology company which engages in the field of protein production in Drosophila Schneider-2 cells. Its services include custom proteins and research & development reagents, process development, and feasibility studies. The company was founded by Charlotte Dyring, Martin Roland Jensen, and Willem Adriaan de Jongh in 2009 and is headquartered in Horsholm, Denmark. | Biotechnology | Director/Board Member | |
Genomic Expression, Inc.
![]() Genomic Expression, Inc. Pharmaceuticals: MajorHealth Technology Genomic Expression, Inc. is an American company that specializes in RNA analysis to detect diseases, monitor health, and design next-generation cures. The company offers COVID19 PCR testing as well as cancer testing. The company was founded by Gitte L. Pedersen and Morten Lorentz Pedersen, with Gitte L. Pedersen serving as the CEO since incorporation. | Pharmaceuticals: Major | Founder | |
StemCare Danmark A/S | Director/Board Member | ||
Cervello A/S | Director/Board Member | ||
Symphogen A/S
![]() Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Corporate Officer/Principal | |
NTG NORDIC TRANSPORT GROUP A/S | Trucking | Chairman | |
Lægernes Test Center A/S | Director/Board Member | ||
StemCare A/S
![]() StemCare A/S BiotechnologyHealth Technology StemCare A/S operates as a private stem cell bank. The firm stores stem cells from umbilical cord blood. The company was founded by Sten Verland in 2003 and is headquartered in Gentofte, Denmark. | Biotechnology | Director/Board Member | |
Biosyntia ApS
![]() Biosyntia ApS BiotechnologyHealth Technology Biosyntia ApS provides services in synthetic biology and metabolic engineering fields. It offers biocatalysts for fermentation of fine chemicals. The company was founded by Andreas Hougaard Laustsen, Morten Otto Alexander Sommer, and Hans Jasper Genee in 2012 and is headquartered in Copenhagen, Denmark. | Biotechnology | Director/Board Member |
Statistik
International
Dänemark | 16 |
Vereinigte Staaten | 3 |
Sektoral
Health Technology | 9 |
Consumer Services | 3 |
Process Industries | 2 |
Producer Manufacturing | 2 |
Transportation | 2 |
Operativ
Director/Board Member | 11 |
Independent Dir/Board Member | 5 |
Corporate Officer/Principal | 4 |
Chief Executive Officer | 2 |
Doctorate Degree | 2 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Karin Garre | 9 |
Sara Sande | 7 |
Gitte L. Pedersen | 5 |
Mattis Ranthe | 2 |
- Börse
- Insiders
- Eske Rygaard-Hjalsted
- Unternehmensverbindungen